Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000697850 | SCV000826482 | uncertain significance | Charcot-Marie-Tooth disease, type 2 | 2018-07-02 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine with proline at codon 710 of the MFN2 protein (p.Leu710Pro). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and proline. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individuals affected with Charcot-Marie-Tooth disease (CMT) (PMID: 16714318, 28660751, Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Inherited Neuropathy Consortium | RCV000789408 | SCV000928763 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only |